185 related articles for article (PubMed ID: 16083330)
21. Myelodysplastic syndromes: the complexity of stem-cell diseases.
Corey SJ; Minden MD; Barber DL; Kantarjian H; Wang JC; Schimmer AD
Nat Rev Cancer; 2007 Feb; 7(2):118-29. PubMed ID: 17251918
[TBL] [Abstract][Full Text] [Related]
22. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
23. The epigenomics revolution in myelodysplasia: a clinico-pathological perspective.
Tan PT; Wei AH
Pathology; 2011 Oct; 43(6):536-46. PubMed ID: 21881538
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in myelodysplastic syndromes.
Shadduck RK; Latsko JM; Rossetti JM; Haq B; Abdulhaq H
Exp Hematol; 2007 Apr; 35(4 Suppl 1):137-43. PubMed ID: 17379099
[TBL] [Abstract][Full Text] [Related]
25. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
Correia ML; Haynes WG
Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
[TBL] [Abstract][Full Text] [Related]
26. Autologous stem cell transplantation in myelodysplastic syndromes.
de Witte T; Suciu S; Brand R; Muus P; Kröger N
Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
[TBL] [Abstract][Full Text] [Related]
27. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract][Full Text] [Related]
28. [Recent advances in the treatment of myelodysplastic syndromes].
Gelsi-Boyer V; Vey N
Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027
[TBL] [Abstract][Full Text] [Related]
29. Emerging therapeutic strategies for myelodysplastic syndrome.
Barrett J; Battiwalla M
Curr Hematol Rep; 2003 May; 2(3):193-201. PubMed ID: 12901340
[TBL] [Abstract][Full Text] [Related]
30. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory drugs in the treatment of myelodysplastic syndromes.
Ortega J; List A
Curr Opin Oncol; 2007 Nov; 19(6):656-9. PubMed ID: 17906467
[TBL] [Abstract][Full Text] [Related]
32. Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS).
List AF
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S31-5. PubMed ID: 16085015
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
[TBL] [Abstract][Full Text] [Related]
34. Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.
Foss FM
Best Pract Res Clin Haematol; 2004 Dec; 17(4):573-84. PubMed ID: 15494295
[TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia and myelodysplastic syndromes in older patients.
Estey E
J Clin Oncol; 2007 May; 25(14):1908-15. PubMed ID: 17488990
[TBL] [Abstract][Full Text] [Related]
36. Advances in the management of low- to intermediate-risk myelodysplastic syndrome: Integrating the National Comprehensive Cancer Network guidelines.
Kurtin SE
Clin J Oncol Nurs; 2006 Apr; 10(2):197-208. PubMed ID: 16708703
[TBL] [Abstract][Full Text] [Related]
37. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Blood Rev; 2008 Mar; 22(2):75-91. PubMed ID: 18068281
[TBL] [Abstract][Full Text] [Related]
38. Myelodysplastic and myeloproliferative disorders in children.
Hasle H
Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
[TBL] [Abstract][Full Text] [Related]
39. Emerging drugs for gastro-oesophageal reflux disease.
Wurm P; De Caestecker J
Expert Opin Emerg Drugs; 2005 May; 10(2):457-71. PubMed ID: 15934879
[TBL] [Abstract][Full Text] [Related]
40. Immunomodulation in myelodysplastic syndromes.
Sekeres MA; List A
Best Pract Res Clin Haematol; 2006; 19(4):757-67. PubMed ID: 16997181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
